Text Messaging Intervention Can Up Glycemic Control in T2DM

Share this content:
Text Messaging Intervention Can Up Glycemic Control in T2DM
Text Messaging Intervention Can Up Glycemic Control in T2DM

FRIDAY, June 16, 2017 (HealthDay News) -- For low-income Hispanic patients with poorly controlled type 2 diabetes, a text messaging intervention can improve glycemic control, according to a study published online June 9 in Diabetes Care.

Addie L. Fortmann, Ph.D., from the Scripps Whittier Diabetes Institute in San Diego, and colleagues conducted a randomized trial involving 126 low-income Hispanic participants with poorly controlled type 2 diabetes. Participants were randomized to receive either the Dulce Digital intervention, which included receipt of up to three motivational, education, and/or call-to-action text messages per day over six months, or usual care.

The researchers found that, compared with usual care, there was a significantly greater reduction in hemoglobin A1c (HbA1c) over time in the Dulce Digital group (P = 0.03). There were no statistically significant effects for secondary clinical indicators. The number of blood glucose values that participants texted in was a significant predictor of HbA1c at month six (P < 0.05). High satisfaction and acceptability ratings were seen for the Dulce Digital intervention.

"Use of a simple, low-cost text-messaging program was found to be highly acceptable in this sample of high-risk, Hispanic individuals with type 2 diabetes and resulted in greater improvement in glycemic control compared with usual care," the authors write.

The Investigator-Initiated Study Program of LifeScan provided glucose testing meters and strips for all participants.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

For patients with relapsed or refractory B-cell ALL who have received one or two prior treatments

Online Nursing Education Can Up Patient Use of VTE Prophylaxis

Online Nursing Education Can Up Patient Use of ...

Online training aims to make sure those hospitalized get treatment to prevent venous thromboembolism

On-Pump CABG Leads to Higher Rates of Five-Year Survival

On-Pump CABG Leads to Higher Rates of Five-Year ...

Study compared coronary-artery bypass grafting surgery, with/without cardiopulmonary bypass

is free, fast, and customized just for you!

Already a member?

Sign In Now »